News Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™ Staff June 25, 2022 Continue Reading Previous Jushi Holdings Inc. Amends and Refiles Q1 2022 Financial StatementsNext Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update More Stories Healthcare News Robotics Comcast, U.S. Conference of Mayors Announce Ten Cities Receiving Grants in Digital Equity Challenge Staff June 21, 2024 Cancer News Nursing Seniors Veterans C&N Teams Raise Over $98,000 for Local Senior Citizens Staff June 21, 2024 Healthcare News Rush University System for Health (RUSH) Advances its Supply Chain with Surgence™ Staff June 21, 2024